Merck

Science

Medical Xpress reports 41% lower progression risk versus chemotherapy in women previously treated with chemotherapy and immunotherapy.

ST

PH

CL

6 Sources, 2h ago, updated 2h ago

Science

Intismeran autogene targets mutations unique to each patient's tumor, STAT reports.

TP

ST

JI

52 Sources, 2h ago, updated 2h ago

Science

STAT News says Moderna's Stephen Hoge discussed the Merck partnership behind an mRNA cancer vaccine at the STAT Summit.

ST

2 Sources, 11d ago, first seen 11d ago

Science

STAT describes Recarbio as an important antibiotic in the US and reports that Merck discontinued it despite concerns over resistance to superbugs.

ST

2 Sources, 27d ago, updated 27d ago